Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_assertion type Assertion NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_head.
- NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_assertion description "[Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_provenance.
- NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_assertion evidence source_evidence_literature NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_provenance.
- NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_assertion SIO_000772 22069160 NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_provenance.
- NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_assertion wasDerivedFrom befree-20150227 NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_provenance.
- NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_assertion wasGeneratedBy ECO_0000203 NP543098.RA3sasOgiO-tH3ZXXRNBhU09oYWAhe19MKlMbZnQnaFL4130_provenance.